Prellis raises $8.7 million for 3D-printed organs

cells-570676_1280.jpg

3D tissue printing startup Prellis Biologics has assembled $8.7 million in new funding alongside positive news from the first transplantation of its vascular tissue scaffolds into animals.

The San Francisco-based company’s series A round was led by Khosla Ventures with additional backing from its previous seed round investors, True Ventures and SOSV’s IndieBio accelerator, to bring its total capital funding to $10.5 million.

Prellis uses laser and holographic printing techniques to build 3D hydrogel structures for R&D or transplantation. This includes its line of ready-to-use biocompatible scaffolds printed with 3D capillaries, known as Vascular Tissue Blanks.

Read more at Fierce Biotech